Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Aljurf

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Journal of Family & Community Medicine|February 28, 2025
Awareness of prostate cancer and its screening tests in men in the Middle East: A systematic review and meta-analysisNawaf S A Mohamed, Joud M O Asfari, Samar M A Sambawa, et al.
Bone Marrow Transplantation|January 27, 2015
Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WPA Lawitschka, M Faraci, I Yaniv, et al.
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Bone Marrow Transplantation|January 5, 2016
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysisK M Williams, K W Ahn, M Chen, et al.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Journal of Family & Community Medicine|February 28, 2025
Awareness of prostate cancer and its screening tests in men in the Middle East: A systematic review and meta-analysisNawaf S A Mohamed, Joud M O Asfari, Samar M A Sambawa, et al.
Bone Marrow Transplantation|January 27, 2015
Paediatric reduced intensity conditioning: analysis of centre strategies on regimens and definitions by the EBMT Paediatric Diseases and Complications and Quality of Life WPA Lawitschka, M Faraci, I Yaniv, et al.
Bone Marrow Transplantation|December 2, 2008
Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity reportM D Aljurf, S Z Zaidi, H El Solh, et al.
Bone Marrow Transplantation|July 10, 2012
Allogeneic hematopoietic stem cell donation-standardized assessment of donor outcome data: a consensus statement from the Worldwide Network for Blood and Marrow Transplantation (WBMT)J P Halter, S M van Walraven, N Worel, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|May 3, 2012
No increased mortality from donor or recipient hepatitis B- and/or hepatitis C-positive serostatus after related-donor allogeneic hematopoietic cell transplantationM Tomblyn, M Chen, M Kukreja, et al.
Bone Marrow Transplantation|November 18, 2014
Alternative donors extend transplantation for patients with lymphoma who lack an HLA matched donorV Bachanova, L J Burns, T Wang, et al.
Bone Marrow Transplantation|January 5, 2016
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysisK M Williams, K W Ahn, M Chen, et al.
Leukemia|August 31, 2013
Ph+ ALL patients in first complete remission have similar survival after reduced intensity and myeloablative allogeneic transplantation: impact of tyrosine kinase inhibitor and minimal residual diseaseV Bachanova, D I Marks, M-J Zhang, et al.
Pageof 1